NCT02298816Withdrawn
B-Cell Hematologic Malignancy Vaccination Registry
Source: ClinicalTrials.gov · Last updated 3 Oct 2024
Reason given: No patients enrolled
Brief summary (registry, in English)
The goal of this study is to develop a vaccination registry system for Aurora Health Care patients newly diagnosed with MM and other B-Cell Hematologic Malignancies in order to prospectively characterize vaccination history and outcomes such as infection in these patients at Aurora Health Care. Additionally hospitalization rates, cost analysis, infection (influenza, pneumonia, other) related to vaccination in this patient population will be evaluated.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 20 Nov 2014
- Start date
- Aug 2014
- Primary completion date
- Dec 2024
- Lead sponsor
- Wake Forest University Health Sciences
- NCT number
- NCT02298816
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- Adult patients at Aurora Health Care who are newly diagnosed with:
- Monoclonal gammopathy of undetermined significance (MGUS),
- Smoldering multiple myeloma (SMM),
- Multiple myeloma (MM),
- Waldenstroms Macroglobulinemia (WM),
- Monoclonal B-cell lymphocytosis (MBL),
- Chronic lymphocytic leukemia (CLL), or
- B-Cell Non-Hodgkin lymphoma (NHL).
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aurora Health Care | Milwaukee | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.